Predictions
Poxel S.A.
Start price
Target price
Perf. (%)
€5.37
24.11.21
24.11.21
€6.00
24.11.22
24.11.22
-24.21%
15.02.22
15.02.22
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€3.51
01.02.22
01.02.22
€4.15
01.02.23
01.02.23
-7.69%
10.02.22
10.02.22
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€15.90
23.01.22
23.01.22
-
23.01.23
23.01.23
-5.47%
06.02.22
06.02.22
Could be very worthwhile Investment >20% year
Theranexus
Start price
Target price
Perf. (%)
€9.02
11.09.21
11.09.21
€10.00
11.09.22
11.09.22
-64.80%
04.02.22
04.02.22
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€4.12
10.01.22
10.01.22
-
10.01.23
10.01.23
-14.85%
01.02.22
01.02.22
Could be worthwhile Investment >10% per year
Visiomed Group
Start price
Target price
Perf. (%)
€0.86
25.01.21
25.01.21
€1.00
25.01.22
25.01.22
-80.01%
24.01.22
24.01.22
Could be worthwhile Investment >10% per year
Crossject S.A.
Start price
Target price
Perf. (%)
€3.67
21.01.21
21.01.21
€10.00
21.01.22
21.01.22
-28.61%
22.01.22
22.01.22
Could be very worthwhile Investment >20% year
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€8.16
15.01.21
15.01.21
-
15.01.22
15.01.22
-63.58%
16.01.22
16.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Valneva SE
Start price
Target price
Perf. (%)
€19.03
04.01.22
04.01.22
-
04.01.23
04.01.23
-7.46%
07.01.22
07.01.22
Risky Investment
Valneva SE
Start price
Target price
Perf. (%)
€23.36
12.12.21
12.12.21
-
12.12.22
12.12.22
8.73%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year
Pixium Vision S.A.
Start price
Target price
Perf. (%)
€1.03
17.02.21
17.02.21
€3.00
17.02.22
17.02.22
-24.32%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year
Leading role in innovation
Future proof or reliable business model
Valneva SE
Start price
Target price
Perf. (%)
€23.36
11.12.21
11.12.21
€30.00
11.12.22
11.12.22
8.73%
25.12.21
25.12.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Euromedis Groupe
Start price
Target price
Perf. (%)
€22.15
12.04.21
12.04.21
€28.35
12.04.22
12.04.22
-51.96%
24.12.21
24.12.21
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€12.34
13.09.21
13.09.21
€9.00
13.09.22
13.09.22
100.65%
16.12.21
16.12.21
Could be very worthwhile Investment >20% year